Affimed N.V.股价重挫18.36% 市值跌32.92万美元

市场透视2025-05-14

北京时间2025年05月14日21时32分，Affimed N.V.（AFMD.us）股票出现波动，股价大幅下跌18.36%。截至发稿，该股报0.109美元/股，成交量99.8579万股，换手率6.09%，振幅7.39%。最近的财报数据显示，该股实现营业收入170274.48美元，净利润-16.63百万美元，每股收益-1.03美元，毛利--，市盈率-0.02倍。机构评级方面，在所有2家参与评级的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535781150?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-14 21:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535781150","market":"us","top_or_hot":-1,"title":"Affimed N.V.股价重挫18.36% 市值跌32.92万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月14日21时32分，Affimed N.V.（AFMD.us）股票出现波动，股价大幅下跌18.36%。截至发稿，该股报0.109美元/股，成交量99.8579万股，换手率6.09%，振幅7.39%。最近的财报数据显示，该股实现营业收入170274.48美元，净利润-16.63百万美元，每股收益-1.03美元，毛利--，市盈率-0.02倍。机构评级方面，在所有2家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213208a6df08a5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Affimed N.V.股价重挫18.36% 市值跌32.92万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAffimed N.V.股价重挫18.36% 市值跌32.92万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-14 21:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213208a6df08a5&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月14日21时32分，Affimed N.V.（AFMD.us）股票出现波动，股价大幅下跌18.36%。截至发稿，该股报0.109美元/股，成交量99.8579万股，换手率6.09%，振幅7.39%。最近的财报数据显示，该股实现营业收入170274.48美元，净利润-16.63百万美元，每股收益-1.03美元，毛利--，市盈率-0.02倍。机构评级方面，在所有2家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213208a6df08a5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213208a6df08a5&s=b","article_id":"2535781150","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213208a6df08a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535781150","pubTimestamp":1747229528,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月14日21时32分，Affimed N.V.股票出现波动，股价大幅下跌18.36%。截至发稿，该股报0.109美元/股，成交量99.8579万股，换手率6.09%，振幅7.39%。Affimed N.V.股票所在的生物技术行业中，整体涨幅为0.12%。Affimed N.V.公司简介：Affimed NV是一家处于临床阶段的生物制药公司。该信息摘要如下：富国银行：下调Affimed评级，由增持调整至持股观望评级, 目标价由11.00美元调整至0.10美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","AFMD":"Affimed NV","AFMDQ":"Affimed N.V.","BK4139":"生物科技","SEPN":"Septerna, Inc."},"translate_title":"Affimed N.V. 's stock plunges 18.36%, its market value falls by $329,200","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AFMDQ":0.9,"SEPN":0.8,"AFMD":0.9},"content_text":"北京时间2025年05月14日21时32分，Affimed N.V.（AFMD.us）股票出现波动，股价大幅下跌18.36%。截至发稿，该股报0.109美元/股，成交量99.8579万股，换手率6.09%，振幅7.39%。最近的财报数据显示，该股实现营业收入170274.48美元，净利润-16.63百万美元，每股收益-1.03美元，毛利--，市盈率-0.02倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。Affimed N.V.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Septerna, Inc.、蓝鸟生物、Quoin Pharmaceuticals Ltd涨幅较大，Nucana Plc、Quoin Pharmaceuticals Ltd、Polyrizon Ltd.较为活跃，换手率分别为1971.30%、1181.45%、1073.83%，振幅较大的相关个股有Nucana Plc、Septerna, Inc.、Quoin Pharmaceuticals Ltd，振幅分别为23.40%、15.45%、14.94%。Affimed N.V.公司简介：Affimed NV是一家处于临床阶段的生物制药公司。该公司致力于发现和开发癌症靶向免疫疗法。其候选产品正在开发免疫肿瘤学领域，这是一种利用人体的免疫防御能力来对抗肿瘤细胞的癌症治疗方法。它以其核心技术积极致力于抗体的发现、临床前和临床开发。 该公司通过向第三方提供基于集团和第三方拥有的知识产权的研发服务来获得收入。 从地理位置来看，该公司的大部分收入来自美国，并且在德国和德国也有业务。消息层面，截至21时32分，《富国银行：下调Affimed评级，由增持调整至持股观望评级, 目标价由11.00美元调整至0.10美元。》资讯为影响Affimed N.V.的重要信息。该信息摘要如下：富国银行：下调Affimed(AFMD.US)评级，由增持调整至持股观望评级, 目标价由11.00美元调整至0.10美元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535781150","isCrawlerRequest":true}